Does Rallies show Form 4 insider transactions for XAIR?

Yes. Rallies tracks XAIR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is XAIR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XAIR. It does not provide personalized investment advice.

XAIR (Beyond Air, Inc. Common Stock) Stock Analysis - Insider Trades

Beyond Air, Inc. Common Stock (XAIR) is a publicly traded Healthcare sector company. As of May 21, 2026, XAIR trades at $0.40 with a market cap of $6.11M and a P/E ratio of -0.57. XAIR moved -8.26% today. Year to date, XAIR is -51.15%; over the trailing twelve months it is -89.56%. Its 52-week range spans $0.38 to $13.52. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces XAIR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading XAIR stock inside the company?

Recent XAIR insider activity includes Lisi Steven A. bought 6.00K, Carey Robert bought 990.00K, Carey Robert bought 10.00K, Gaul Michael A. bought 6.00K, and Carey Robert bought 1.48M. Rallies tracks insider transaction dates, shares, prices, and estimated values.

XAIR Key Metrics

Key financial metrics for XAIR
Metric	Value
Price	$0.40
Market Cap	$6.11M
P/E Ratio	-0.57
EPS	$-0.69
Dividend Yield	0.00%
52-Week High	$13.52
52-Week Low	$0.38
Volume	6.82K
Avg Volume	0
Revenue (TTM)	$3.71M
Net Income	$-48.48M
Gross Margin	-44.88%

Recent XAIR Insider Trades

Lisi Steven A. bought 6.00K (~$19.49K) on Jul 21, 2025.
Carey Robert bought 990.00K (~$247.50K) on Mar 14, 2025.
Carey Robert bought 10.00K (~$2.55K) on Mar 14, 2025.
Gaul Michael A. bought 6.00K (~$2.29K) on Feb 19, 2025.
Carey Robert bought 1.48M (~$744.66K) on Sep 26, 2024.

Latest XAIR News

Beyond Cancer Sees 6 of 10 Patients Alive 22-40 Months Post-UNO; Patent Allowance Granted — Apr 20, 2026
Beyond Air Secures Top-Three GPO Deal for LungFit PH Access in 2,000 Hospitals — Apr 1, 2026
Beyond Air Appoints Robert Goodman as CEO to Drive LungFit PH Expansion — Mar 26, 2026
27-Study Review Bolsters High-Dose iNO’s Broad-Spectrum Antimicrobial Potential — Feb 20, 2026
Beyond Air Q3 Revenue Up 105% to $2.2M, Signs $32.5M NeuroNOS Deal — Feb 13, 2026

XAIR Analyst Consensus

2 analysts cover XAIR: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.

Common questions about XAIR

Who is trading XAIR stock inside the company?: Recent XAIR insider activity includes Lisi Steven A. bought 6.00K, Carey Robert bought 990.00K, Carey Robert bought 10.00K, Gaul Michael A. bought 6.00K, and Carey Robert bought 1.48M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for XAIR?: Yes. Rallies tracks XAIR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is XAIR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XAIR. It does not provide personalized investment advice.